health ๐ฌ Europe's advanced therapies face new regulatory challenges
Professor Jacob George discussed the evolving regulatory landscape for Advanced Therapy Medicinal Products (ATMPs) at Advanced Therapies Europe in Barcelona. He explained that ATMPs, like cell & gene therapies, pose challenges due to their patient-specific and complex nature. Key points included the need for proportionate regulation and regulatory agility to support innovation. International collaboration is crucial to reduce costs and ensure timely patient access to these transformative treatments. Frameworks must evolve alongside the science to maintain both safety and high-quality standards.